Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alchemab Therapeutics
Biotech
Cue Biopharma queues up J&J vet as CBO—Chutes & Ladders
Cue Biopharma queues up J&J vet as CBO. Transgene taps two new oncology leaders. Cassava looks to steady ship with new CEO.
Darren Incorvaia
,
Zoey Becker
Sep 13, 2024 8:30am
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
May 27, 2022 9:30am
Lightstone raises $375M for third fund after 3 big exits in 2020
Sep 14, 2021 10:05am
Alchemab picks up new well-connected CEO
Jun 22, 2021 10:25am
AstraZeneca taps antibody miner Alchemab for prostate R&D deal
May 5, 2021 10:25am
